Literature DB >> 34363037

Trajectories of kidney function in diabetes: a clinicopathological update.

Megumi Oshima1, Miho Shimizu1, Masayuki Yamanouchi1,2, Tadashi Toyama1, Akinori Hara1, Kengo Furuichi3, Takashi Wada4.   

Abstract

Diabetic nephropathy has been traditionally diagnosed based on persistently high albuminuria and a subsequent decline in glomerular filtration rate (GFR), which is widely recognized as the classical phenotype of diabetic kidney disease (DKD). Several studies have emphasized that trajectories of kidney function in patients with diabetes (specifically, changes in GFR and albuminuria over time) can differ from this classical DKD phenotype. Three alternative DKD phenotypes have been reported to date and are characterized by albuminuria regression, a rapid decline in GFR, or non-proteinuric or non-albuminuric DKD. Although kidney biopsies are not typically required for the diagnosis of DKD, a few studies of biopsy samples from patients with DKD have demonstrated that changes in kidney function associate with specific histopathological findings in diabetes. In addition, various clinical and biochemical parameters are related to trajectories of GFR and albuminuria. Collectively, pathological and clinical characteristics can be used to predict trajectories of GFR and albuminuria in diabetes. Furthermore, cohort studies have suggested that the risks of kidney and cardiovascular outcomes might vary among different phenotypes of DKD. A broader understanding of the clinical course of DKD is therefore crucial to improve risk stratification and enable early interventions that prevent adverse outcomes.
© 2021. Springer Nature Limited.

Entities:  

Year:  2021        PMID: 34363037     DOI: 10.1038/s41581-021-00462-y

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  103 in total

1.  Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes.

Authors:  Shin-ichi Araki; Masakazu Haneda; Toshiro Sugimoto; Motohide Isono; Keiji Isshiki; Atsunori Kashiwagi; Daisuke Koya
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

Review 2.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

3.  An autopsy study suggests that diabetic nephropathy is underdiagnosed.

Authors:  Celine Q F Klessens; Tess D Woutman; Kimberley A M Veraar; Malu Zandbergen; Elisabeth J J Valk; Joris I Rotmans; Ron Wolterbeek; Jan A Bruijn; Ingeborg M Bajema
Journal:  Kidney Int       Date:  2016-04-09       Impact factor: 10.612

4.  Silent diabetic nephropathy.

Authors:  Samar M Said; Samih H Nasr
Journal:  Kidney Int       Date:  2016-07       Impact factor: 10.612

5.  Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.

Authors:  K Rossing; P K Christensen; P Hovind; H-H Parving
Journal:  Diabetologia       Date:  2005-09-17       Impact factor: 10.122

6.  Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Authors:  Josef Coresh; Hiddo J L Heerspink; Yingying Sang; Kunihiro Matsushita; Johan Arnlov; Brad C Astor; Corri Black; Nigel J Brunskill; Juan-Jesus Carrero; Harold I Feldman; Caroline S Fox; Lesley A Inker; Areef Ishani; Sadayoshi Ito; Simerjot Jassal; Tsuneo Konta; Kevan Polkinghorne; Solfrid Romundstad; Marit D Solbu; Nikita Stempniewicz; Benedicte Stengel; Marcello Tonelli; Mitsumasa Umesawa; Sushrut S Waikar; Chi-Pang Wen; Jack F M Wetzels; Mark Woodward; Morgan E Grams; Csaba P Kovesdy; Andrew S Levey; Ron T Gansevoort
Journal:  Lancet Diabetes Endocrinol       Date:  2019-01-08       Impact factor: 32.069

7.  Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

Authors:  Maryam Afkarian; Leila R Zelnick; Yoshio N Hall; Patrick J Heagerty; Katherine Tuttle; Noel S Weiss; Ian H de Boer
Journal:  JAMA       Date:  2016-08-09       Impact factor: 56.272

8.  Remission of nephrotic-range albuminuria in type 1 diabetic patients.

Authors:  P Hovind; P Rossing; L Tarnow; H Toft; J Parving; H H Parving
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

Review 9.  The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.

Authors:  C E Mogensen; C K Christensen; E Vittinghus
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

10.  Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial.

Authors:  Megumi Oshima; Brendon L Neuen; JingWei Li; Vlado Perkovic; David M Charytan; Dick de Zeeuw; Robert Edwards; Tom Greene; Adeera Levin; Kenneth W Mahaffey; Luca De Nicola; Carol Pollock; Norman Rosenthal; David C Wheeler; Meg J Jardine; Hiddo J L Heerspink
Journal:  J Am Soc Nephrol       Date:  2020-09-30       Impact factor: 10.121

View more
  16 in total

1.  Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1.

Authors:  Shuqin Mei; Lin Li; Xiangjun Zhou; Cheng Xue; Man J Livingston; Qingqing Wei; Bing Dai; Zhiguo Mao; Changlin Mei; Zheng Dong
Journal:  FASEB J       Date:  2022-08       Impact factor: 5.834

2.  A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease.

Authors:  Girish N Nadkarni; Dipti Takale; Bruce Neal; Kenneth W Mahaffey; Yshai Yavin; Michael K Hansen; Fergus Fleming; Hiddo J L Heerspink; Steven G Coca
Journal:  Kidney360       Date:  2022-05-18

3.  Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies.

Authors:  Haojia Wu; Romer Gonzalez Villalobos; Xiang Yao; Dermot Reilly; Tao Chen; Matthew Rankin; Eugene Myshkin; Matthew D Breyer; Benjamin D Humphreys
Journal:  Cell Metab       Date:  2022-06-15       Impact factor: 31.373

4.  Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Shaomin Shi; Lihua Ni; Ling Gao; Xiaoyan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

5.  Objective study of the facial parameters of observations in patients with type 2 diabetes mellitus by machine learning.

Authors:  Baozhi Cheng; Jianli Ma; Xiaolong Chen; Lingyan Yuan
Journal:  Ann Transl Med       Date:  2022-09

6.  Reducing lipid bilayer stress by monounsaturated fatty acids protects renal proximal tubules in diabetes.

Authors:  Albert Pérez-Martí; Suresh Ramakrishnan; Jiayi Li; Aurelien Dugourd; Martijn R Molenaar; Luigi R De La Motte; Kelli Grand; Anis Mansouri; Mélanie Parisot; Soeren S Lienkamp; Julio Saez-Rodriguez; Matias Simons
Journal:  Elife       Date:  2022-05-12       Impact factor: 8.713

Review 7.  Novel Markers in Diabetic Kidney Disease-Current State and Perspectives.

Authors:  Agnieszka Piwkowska; Łukasz Zdrojewski; Zbigniew Heleniak; Alicja Dębska-Ślizień
Journal:  Diagnostics (Basel)       Date:  2022-05-11

Review 8.  Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts.

Authors:  Johannes Pöhlmann; Klas Bergenheim; Juan-Jose Garcia Sanchez; Naveen Rao; Andrew Briggs; Richard F Pollock
Journal:  Diabetes Ther       Date:  2022-03-15       Impact factor: 2.945

9.  Trends and Outcomes of Aortic Valve Replacement in Patients With Diabetes in the US.

Authors:  Sarah Khan; Soha Dargham; Jassim Al Suwaidi; Hani Jneid; Charbel Abi Khalil
Journal:  Front Cardiovasc Med       Date:  2022-03-18

10.  Letter Regarding "Moderating Effects in Randomized Trials-Interpreting the P Value, Confidence Intervals, and Hazard Ratios".

Authors:  Jorge Rico-Fontalvo; Rodrigo Daza-Arnedo; Maria Raad-Sarabia; José Restom-Arrieta; José Bohórquez-Rivero
Journal:  Kidney Int Rep       Date:  2022-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.